Vivek Uttam
Vivek Uttam is an expert in Oncology at Central University of Punjab (India). Vivek Uttam has authored 22 publications, the most recent in 2026. SLR score: 61 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Immunology - Biochemistry - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2022 - 2026
Number : 22
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Overcoming immune resistance through tumor microenvironment reprogramming: Emerging immunotherapeutic strategies and translational advances. PMID 42562333 — cells, genes, neoplasms, therapeutics, t-lymphocytes, cell death, tumor microenvironment | Biochem Pharmacol | 2026 | 0 |
| Comparative clinical significance of HPV DNA, HPV E6/E7 mRNA, and p16 INK4a in cervical cancer among Indian and USA populations: a meta-analysis and systematic review. PMID 42409895 — uterine cervical neoplasms, neoplasms, rna, messenger, biomarkers, cyclin-dependent kinase inhibitor p16, dna, genes, p16 | Sci Rep | 2026 | 0 |
| Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer. PMID 42002235 — cells, tumor necrosis factor-alpha, biochemistry, chemistry, pharmaceutical, neoplasms, immunotherapy, therapeutics, esophageal neoplasms, rna, long noncoding | Biochem Pharmacol | 2026 | 0 |
| Comprehensive review on outcomes from Phase 3 clinical trials of drugs in multiple myeloma. PMID 41319363 — cells, antibodies, pharmaceutical preparations, dexamethasone, neoplasms, multiple myeloma, lenalidomide, transplants, therapeutics | Cancer Treat Res Commun | 2025 | 0 |
| MYOSLID: A Critical Modulator of Cancer Hallmarks. PMID 40149492 — cells, genomics, neoplasms, biomarkers, squamous cell carcinoma of head and neck, neoplasm metastasis, therapeutics, colorectal neoplasms, stomach neoplasms, osteosarcoma, immune evasion | Genes (Basel) | 2025 | 0 |
LeadR Networks
Main global connection map